Private Equity

Healthcare

PE-backed GMR sets IPO pricing terms

Based in Lewisville, Texas, GMR is a provider of emergency medical services.

1 min read · 04 May 2026

SK Capital completes sale of Noramco, Extractas Biosciences and Purisys to Siegfried Holding

SK Capital will retain ownership of Halo Pharmaceuticals, a finished-dose-form CDMO in the US and Canada.

2 min read · 04 May 2026

Carlyle acquires health tech firms Knack RCM and EqualizeRCM

Rajiv Sharma, founder of Knack RCM, and Nagi Rao, founder of EqualizeRCM, will remain invested in the platform through a reinvestment of a portion of their proceeds.

1 min read · 04 May 2026

New PE firm Mako officially rolls out

The co-founders include Oscar Munoz, the former chairman and CEO of United Airlines.

2 min read · 01 May 2026

Goldman Sachs, GHO, MidEuropa set sights on eye care; Medical component demand drives Artemis’ acquisition of Optikos

With sizable and stable EBITDA multiples, ophthalmology assets have become highly sought after by private equity.

5 min read · 01 May 2026

ArchiMed to take Esperion Therapeutics private for $1.1bn

The transaction is expected to close in the third quarter of 2026.

1 min read · 01 May 2026

PE targets eye care assets: 6 deals

Goldman Sachs, Gryphon Investors, MidEuropa and Olympus are among the PE firms eying platform investments and consolidation in eye care.

4 min read · 01 May 2026

3 Boomerang-backed Pinnaql snaps up Pharma Resource Group

The deal marks the third tuck-in acquisition Pinnaql has completed in the past 10 months.

1 min read · 30 April 2026

vox populi

Healthcare M&A in 2026: Five rules smart sponsors are following

Dealmaking is on the upswing, but sponsors need to rethink their methods to get to the finish line, writes Matthew Brohm of Arnall Golden Gregory.

3 min read · 29 April 2026

Archimed, La Caisse acquire Stago

Stago develops and manufactures hemostasis equipment and reagents.

1 min read · 29 April 2026

Showing 341 to 350 of 5,654 results
1…3436…566